TBVI Receives $3 Million Grant

LELYSTAD, Netherlands -- TuBerculosis Vaccine Initiative (TBVI) recently received a $3 million grant for a three year term from the Bill & Melinda Gates Foundation. This grant enables the nonprofit organization to strengthen its fundraising and communication activities in order to increase awareness and support for tuberculosis (TB) vaccine research and raise funds for the development of safer and more effective vaccines. For the full press release, visit the TuBerculosis Vaccine Initiative (TBVI) web site.

###
Bill & Melinda Gates Foundation
Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives. In developing countries, it focuses on improving people’s health and giving them the chance to lift themselves out of hunger and extreme poverty. In the United States, it seeks to ensure that all people—especially those with the fewest resources—have access to the opportunities they need to succeed in school and life. Based in Seattle, Washington, the foundation is led by CEO Jeff Raikes and Co-chair William H. Gates Sr., under the direction of Bill and Melinda Gates and Warren Buffett.

Related Grant

Tuberculosis Vaccine Initiative

ONLINE RESOURCES

TuBerculosis Vaccine Initiative (TBVI)

PRESS RELEASES

Mar 10, 2010Draft K-12 Common Core State Standards Available for Comment Mar 08, 2010Cabrillo College’s Academy for College Excellence Receives $3.6 Million to Expand …Mar 08, 2010Foundation Announces New Global Health Leadership Appointments